Scarica l'app Stockscreener
57.28
2.63%
1.47
Dopo l'orario di chiusura:
57.58
0.30
+0.52%
Precedente Chiudi:
$55.81
Aprire:
$56.29
Volume 24 ore:
645.57K
Relative Volume:
0.63
Capitalizzazione di mercato:
$2.91B
Reddito:
$534.53M
Utile/perdita netta:
$-11.45M
Rapporto P/E:
-237.58
EPS:
-0.2411
Flusso di cassa netto:
$48.28M
1 W Prestazione:
+1.61%
1M Prestazione:
+5.02%
6M Prestazione:
+102.90%
1 anno Prestazione:
+58.32%
Intervallo 1D:
$55.67
$57.35
Intervallo di 1 settimana:
$51.63
$57.35
Portata 52W:
$25.36
$61.70
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, RMD, MDLN, ALC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
57.28 | 2.91B | 534.53M | -11.45M | 48.28M | -0.2411 |
ISRG
Intuitive Surgical Inc
|
427.64 | 151.08B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.89 | 51.45B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
234.60 | 32.99B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.76 | 31.37B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.35 | 31.11B | 10.63B | 819.00M | 1.59B | 1.6577 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-18 | Downgrade | Oppenheimer | Outperform → Perform |
| 2026-02-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
AtriCure stock fell 4.8 percent as analysts reset targets - AD HOC NEWS
A Look at AtriCure Inc (ATRC) After 4.8% Decline -- GF Value $40 - GuruFocus
BlackRock reports its AtriCure (ATRC) stake and identifies an iShares ETF with over 5% interest. - Stock Titan
AtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And Risks - Yahoo Finance
Freedom Capital downgrades AtriCure stock rating to hold, raises price target to $57 - Investing.com Nigeria
Freedom Capital downgrades AtriCure stock rating to hold, raises price target to $57 - Investing.com Canada
AtriCure, Inc. (ATRC) Stock forecasts - Yahoo Finance UK
AtriCure, Inc. (ATRC) Stock Forecasts - Yahoo! Finance Canada
Price to cash flow ratio of AtriCure, Inc. – HAN:A5I - TradingView
AtriCure, Inc. (ATRC) Stock Forecasts - Yahoo Finance
AtriCure Inc (ATRC) Shares Fall 3.2% -- GF Value Says Still Over - GuruFocus
ETFs Investing in AtriCure, Inc. Stocks - TradingView
Debt to assets ratio of AtriCure, Inc. – HAN:A5I - TradingView
Return on equity % of AtriCure, Inc. – HAN:A5I - TradingView
AtriCure, Inc. Actuals & Estimates (HAN:A5I) - TradingView
AtriCure (ATRC) Stock Looks Rich Against Its Sales Base - finance.yahoo.com
AtriCure Inc (ATRC) Shares Fall 3.9% -- What GF Score of 77 Tells Investors - GuruFocus
AtriCure CTO Salvatore Privitera sells $271,140 in stock - Investing.com
Form 4 AtriCure Inc For: 24 September By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 4,519 Shares - GuruFocus
Atricure Insider Sold Shares Worth $271,140, According to a Recent SEC Filing - marketscreener.com
AtriCure (ATRC) officer sells shares at $60 each under a trading plan. - Stock Titan
AtriCure, Inc. (ATRC) Stock Forecasts - Yahoo! Finance Canada
AtriCure, Inc. (ATRC) Stock Forecasts - finance.yahoo.com
After two September sales, AtriCure (ATRC) officer Salvatore Privitera proposes another worth $271,140. - Stock Titan
AtriCure stock hits 52-week high at $59.91 - Investing.com
AtriCure, Inc.(NasdaqGM: ATRC) added to S&P 1000 - marketscreener.com
Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year? - finance.yahoo.com
AtriCure director Regina Groves sells $288,070 of stock - Investing.com
AtriCure Executive Stock Sale Analysis - Intellectia AI
AtriCure CTO Sells 3,657 Shares - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Nigeria
AtriCure (ATRC) Chief Technical Officer Salvatore Privitera Sells 3,657 Shares - GuruFocus
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Australia
Do Options Traders Know Something About AtriCure Stock We Don't? - Yahoo Finance
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com Canada
AtriCure CTO Salvatore Privitera sells $201,135 in shares - investing.com
AtriCure CTO Salvatore Privitera sells $201,135 in shares By Investing.com - Investing.com India
AtriCure CTO Salvatore Privitera sells $201,135 in shares - Investing.com
AtriCure (ATRC) CTO discloses pre-set stock sale - Stock Titan
AtriCure, Inc. (ATRC) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
How Atricure Inc. (ATRC) Affects Rotational Strategy Timing - Stock Traders Daily
AtriCure (ATRC) Momentum Meets A Pricey Narrative On $47 Fair Value - simplywall.st
AtriCure CTO Privitera Sells 7,763 Shares at $52.50 Each (NASDAQ: ATRC) - Kalkine Media
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com India
AtriCure at Wells Fargo conference: growth and margins run ahead By Investing.com - Investing.com UK
Atricure CTO Salvatore Privitera sells $407,557 in stock By Investing.com - Investing.com South Africa
AtriCure CTO Salvatore Privitera Sells 7,763 Shares via 10b5-1 Trading Plan - Kalkine Media
AtriCure Inc (ATRC) Chief Technical Officer Salvatore Privitera Sells 7,763 Shares - GuruFocus
Atricure CTO Salvatore Privitera sells $407,557 in stock - Investing.com
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atricure Inc Azioni (ATRC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SALVATORE PRIVITERA | Officer |
Sep 23 '26 |
Proposed Sale |
60.00 |
4,519 |
271,140 |
0 |
| GROVES REGINA E | Director |
Sep 11 '26 |
Sale |
54.22 |
5,313 |
288,071 |
34,546 |
| GROVES REGINA E | Director |
Sep 10 '26 |
Proposed Sale |
53.66 |
5,313 |
285,096 |
0 |
| Privitera Salvatore | Chief Technical Officer |
Sep 08 '26 |
Sale |
55.00 |
3,657 |
201,135 |
147,264 |
| SALVATORE PRIVITERA | Officer |
Sep 08 '26 |
Proposed Sale |
55.00 |
3,657 |
201,135 |
0 |
| Privitera Salvatore | Chief Technical Officer |
Sep 02 '26 |
Sale |
52.50 |
7,763 |
407,558 |
150,921 |
| SALVATORE PRIVITERA | Officer |
Sep 02 '26 |
Proposed Sale |
52.50 |
7,763 |
407,558 |
0 |
| Dahlquist Karl S. | Chief Legal Officer |
Aug 24 '26 |
Sale |
48.89 |
9,370 |
458,099 |
87,319 |
| KARL DAHLQUIST | Officer |
Aug 24 '26 |
Proposed Sale |
48.89 |
9,370 |
458,091 |
0 |
| Prange Karen | Director |
Aug 05 '26 |
Sale |
38.80 |
3,564 |
138,283 |
22,809 |
2.73%
1.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):